Found: 4
Select item for more details and to access through your institution.
Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu<sup>™</sup> electronic nicotine delivery systems (ENDS).
- Published in:
- Internal & Emergency Medicine, 2022, v. 17, n. 2, p. 397, doi. 10.1007/s11739-021-02813-w
- By:
- Publication type:
- Article
Mechanistic Evaluation of the Impact of Smoking and Chronic Obstructive Pulmonary Disease on the Nasal Epithelium.
- Published in:
- Clinical Medicine Insights: Circulatory, Respiratory & Pulmonary Medicine, 2017, n. 11, p. 1, doi. 10.1177/1179548417710928
- By:
- Publication type:
- Article
A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes.
- Published in:
- Psychopharmacology, 2022, v. 239, n. 9, p. 2931, doi. 10.1007/s00213-022-06178-6
- By:
- Publication type:
- Article
Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2006, v. 173, n. 7, p. 769, doi. 10.1164/rccm.200505-717OC
- By:
- Publication type:
- Article